JNJHealth carePharmaceuticals
$266.17
Close on Nov 3, 2026
$640.8B
Johnson & Johnson develops prescription medicines, for areas such as cancer and immune diseases, and medical devices such as surgical tools and heart devices.
As reported in the company's annual report (10-K).
Useful context, but not the main focus.
Drag across the chart to compare two days.Touch the chart with two fingers to compare two days.
What it is · Why it matters · How to read it in context.
Annual figures, fiscal years 2021-2025.
Financial figures come from company filings with the U.S. Securities and Exchange Commission (SEC). Latest filing used: October 21, 2026. Stock prices are end-of-day closing prices.